0A8E fundamentals
An in-depth look to XERIS BIOPHARMA HLDGS INC COM USD0.0001 operating, investing, and financing activities
0A8E free cash flow for Q1 24 is -20.47 M USD. For 2023, 0A8E free cash flow was -50.47 M USD and operating cash flow was -48.21 M USD.
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
TTM